|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 PENNSYLVANIA AVENUE, NW, SOUTH BUILDING |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 1581-12
|
||||||||
|
6. House ID# 306290000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: MARY BETH DONAHUE, EXECUTIVE VICE PRESIDENT |
Date | 10/19/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5, HEALTH Act (Gingrey) IPAB repeal, medical liability reform, McCarran-Ferguson;
16. Specific Lobbying Issues (continued):
H.R. 452, Medicare Decisions Accountability Act (Roe) IPAB repeal, medical liability reform, McCarran-Ferguson
H.R.611 -- BEST PRACTICES Act (Rush) data security
H.R. 1173, Fiscal Responsibility and Retirement Security Act (Boustany) National Clearinghouse for LTC Information
H.R. 1409, Quality Health Care Coalition Act (Conyers) antitrust exemption for physicians
H.R. 1707, Data Accountability and Trust Act (Rush) data security
H.R. 1841, Data Accountability and Trust Act (Stearns) data security
H.R. 2576, (Black) eligibility for health care assistance
H.R. 2577, Secure and Fortify Electronic Data Act (Bono Mack) data security
H.R. 2676, Small Business Health Relief Act (Schweikert) repeal of premium tax and other ACA provisions
H.R. 5800, Health Care Price Transparency Promotion Act (Burgess) price transparency
H.R. 5909, Comprehensive Dental Reform Act (Cummings) expanded access to dental services
Labor, HHS, Education Appropriations Act (Rehburg) funding for HHS programs and agencies
H.J.Res. 17, Continuing Appropriations Resolution (Rogers) temporary appropriations for FY 2013
S. 1049, Small Business Health Relief Act (Kyl) repeal of premium tax and other ACA provisions
S. 1099, HEALTH Act (Blunt) medical liability reform
S. 1151, Personal Data Privacy and Security Act (Leahy) privacy, data security
S. 1207, Data Security and Breach Notification Act (Pryor) data security
S. 1408, Data Breach Notification Act (Feinstein) data security
S. 1535, Personal Data Protection and Breach Accountability Act (Blumenthal) data security
S. 1789, 21st Century Postal Service Act (Lieberman) -- health benefits for postal employees
S. 2111, Cyber Crime Protection Security Act (Leahy) privacy
S. 3272, Comprehensive Dental Reform Act (Sanders) expanded access to dental services
S. 3295, Labor, HHS, Education Appropriations Act (Harkin) funding for HHS programs and agencies, ACA related amendments
S. 3333, Data Security and Breach Notification Act (Toomey) data security
S. 3351, Protect Our Health Privacy Act (Franken) privacy
S. 3414, Cybersecurity Act (Lieberman) privacy, data security
S. 3432 Identity Theft and Tax Fraud Prevention Act (Nelson/Coburn) privacy
Regulatory Issues:
HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets, identifiers including the health plan identifier, enforcement; FEHBP enrollment data clearinghouse initiative, the enrollment reconciliation process, and a related OPM reimbursement factor for records that cannot be reconciled; issues relating to health insurance plan participation in FEHBP, including contract requirements; transition from the similarly sized subscriber group (SSSG) requirement to an MLR; OPM data warehouse; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues relating to quality improvement; issues related to potential priority research topics for the effective health care program; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; issues relating to data breach requirements; issues relating to "meaningful use" requirements for health information technology; issues related to the collection of race and ethnicity data; issues related to medical loss ratios; review of rates for reasonableness; health insurance exchanges; preexisting condition insurance plans; accountable care organizations; coverage of preventive services; contraceptive coverage; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues related to privacy, security, and other regulation of the Internet and electronic commerce; issues relating to the annual fee on health insurance providers; health plan automatic enrollment requirements; health insurance web portal requirements; dependent coverage; summary of benefits and coverage disclosures; and other issues relating to health care reform implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of, Office of Personnel Management (OPM), Agency for Health Care Policy & Research, Internal Revenue Service (IRS), Health Resources & Services Administration (HRSA), Pension & Welfare Benefits Administration, White House Office, Justice - Dept of (DOJ), Office of Management & Budget (OMB),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeremy |
Allen |
|
|
|
Carmella |
Bocchino |
|
|
|
Kathleen |
Callanan |
|
|
|
Mary |
Donahue |
|
|
|
Dan |
Durham |
|
|
|
Paul |
Eiting |
|
|
|
Colleen |
Gallaher |
|
|
|
Gregory |
Gierer |
|
|
|
Donna |
Horoschak |
|
|
|
Karen |
Ignagni |
|
|
|
Erik |
Komendant |
|
|
|
Amber |
Manko |
|
|
|
Thomas |
Meyers |
|
|
|
Julie |
Miller |
|
|
|
Dana |
Mott-Bronson |
|
|
|
Candace |
Schaller |
|
|
|
Jeanette |
Thornton |
|
|
|
Kelly |
Vogel |
|
|
|
Howard |
Weiss |
|
|
|
Thomas |
Wilder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 (Herger)
16. Specific Lobbying Issues (continued):
H.R. 999, Medicare Prescription Drug Savings and Choice Act (Schakowsky) Medicare Part D changes
H.R. 1063, Strengthening Medicare And Repaying Taxpayers Act (Murphy) Medicare secondary payer rules
H.R. 1357, Puerto Rico Medicare Part B Equity Act (Pierluisi)
H.R. 1580, Medicare Beneficiary Preservation of Choice Act (Gonzalez) Medicare Advantage enrollment periods
H.R. 2190, Medicare Drug Savings Act (Waxman) rebates for dual eligibles
H.R. 2248, Medicare Prescription Drug Price Negotiation Act (Welch) Part D price negotiation
H.R. 2770, Medicare Cost Contract Extension Act (Paulsen) extension of Medicare cost plans
H.R. 3399, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act (Roskam/Carney)
H.R. 3519 (Towns) exempting Medicare from sequestration
H.R. 3691, Senior Medicare Fairness Act (Paulsen) frailty adjuster for certain MA SNPs
H.R. 4254, Medicare Advantage Program Integrity Act (Stark) MA payment changes
H.R. 5872, Sequestration Transparency Act (Hensarling)
H.R. 5979, Medicaid Accountability and Care Act (Cassidy) -- federal financing of state Medicaid programs
H.R. 6232, Medicare Better Health Rewards Program Act (Paulsen) incentives for wellness and prevention
H.R. 6300, Medicaid Long-Term Care Reform Act (Boustany) LTC and Medicaid issues
S. 31, Prescription Drug and Health Improvement Act (Franken) Part D price negotiation
S. 44, Medicare Prescription Drug Price Negotiation Act (Klobuchar) Part D price negotiation
S. 560, Medicare Prescription Drug Savings and Choice Act (Durbin) Medicare Part D changes
S. 1206, Medicare Drug Savings Act (Rockefeller) rebates for dual eligibles
S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act (Coburn/Carper)
S. 1479, Medicare Beneficiary Preservation of Choice Act (Casey) Medicare Advantage enrollment periods
S. 1497, Medicare Cost Contract Extension Act (Klobuchar) extension of Medicare cost plans
S. 1999, Senior Medicare Fairness Act (Klobuchar) frailty adjuster for certain MA SNPs
S. 2196, Congressional Health Care for Seniors Act (Paul) reforms affecting Medicare and Medigap
S. 2243, Medicare Better Health Rewards Program Act (Wyden-Portman) incentives for wellness and prevention
Regulatory Issues:
Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, data, and audit issues; bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, and audits); Medicare Medical Loss Ratio issues raised by initial implementation in 2014; implications of sequestration in 2013 for Medicare Advantage and Part D plans; application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, SSA and CMS premium withhold processing issues, enrollment rules, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff; measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training; contracting issues for Dual Eligible Special Needs Plans (SNPs); Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, Part D coverage gap discount program, including employer group waiver plan (EGWP) issues, and other operational issues; MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; implementation of MA and Part D changes made in the Accountable Care Act (ACA), including application of the MA Star Rating system for payment purposes starting 2012 and changes to the Part D coverage gap; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education Program; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicare/Medicaid integration for dual eligibles, including the Capitated Financial Alignment Demonstration; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital
Regulatory Issues (continued):
days in the upper payment limit calculation; policies affecting State Medicaid funding, including block grants, the calculation of the federal medical assistance (federal matching) percentage (FMAP), and intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including Medicaid managed care organization provider tax issues; standards for electronic prescribing; implementation of Medicaid changes of interest to Medicaid health plans made in the ACA including Medicaid expansion, the managed care organization (MCO) prescription drug rebate provisions, minimum payments to primary care providers (PCPs), interactions between the Medicaid program and health insurance exchanges, and Medicaid and CHIP maintenance of effort (MOE) requirements; issues related to Medigap coverage; issues relating to "meaningful use" requirements for health information technology; and other issues relating to health care reform implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Executive Office of the President (EOP), White House Office, Office of Personnel Management (OPM)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeremy |
Allen |
|
|
|
Carmella |
Bocchino |
|
|
|
Kathleen |
Callanan |
|
|
|
Dan |
Durham |
|
|
|
Karen |
Ignagni |
|
|
|
Erik |
Komendant |
|
|
|
Dana |
Mott-Bronson |
|
|
|
Candace |
Schaller |
|
|
|
Jeanette |
Thornton |
|
|
|
Kelly |
Vogel |
|
|
|
Howard |
Weiss |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) FEHBP prescription drugs
16. Specific Lobbying Issues (continued):
H.R.1946, Preserving Hometown Independent Pharmacies Act (Marino) antitrust exemption for independent pharmacies
H.R. 3995, Protecting Consumer Access to Generic Drugs Act (Rush) pay-for-delay settlements
S. 27, Preserve Access to Affordable Generics Act (Kohl) pay-for-delay settlements
S. 2002, Online Pharmacy Safety Act (Feinstein) establishes standards for on-line pharmacies
S. 2193, Ensuring Safe Medical Devices for Patients (Merkley) FDA oversight of medical devices
S. 3187, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues
Regulatory Issues:
Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and other issues relating to health care reform implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeremy |
Allen |
|
|
|
Carmella |
Bocchino |
|
|
|
Kathleen |
Callanan |
|
|
|
Karen |
Ignagni |
|
|
|
Erik |
Komendant |
|
|
|
Dana |
Mott-Bronson |
|
|
|
Candace |
Schaller |
|
|
|
Jeanette |
Thornton |
|
|
|
Kelly |
Vogel |
|
|
|
Howard |
Weiss |
|
|
|
Thomas |
Wilder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R. 63, Long-Term Care Insurance Reform Act (Doggett) LTC insurance reforms
16. Specific Lobbying Issues (continued):
H.R. 111, Breast Cancer Patient Protection Act (DeLauro) minimum hospital stays for mastectomy patients
H.R. 346, Health Care Choice Act (Pearce ) national marketplace for individual coverage
H.R.371, Health Care Choice Act (Blackburn) national marketplace for individual coverage
H.R. 416, Health Insurance Rate Review Act (Schakowsky) rate review
H.R. 1050, Small Business Health Fairness Act (Johnson) association health plans
H.R. 1150, Competitive Health Insurance Reform Act (Gosar) antitrust policy
H.R.1206, Access to Professional Health Insurance Advisors Act (Rogers) agent commissions, medical loss ratios
H.R. 1943, Health Insurance Industry Fair Competition Act (DeFazio) changes to McCarran-Ferguson Act
H.R. 2077, MLR Repeal Act (Price) medical loss ratios
H.R. 2645, Medigap Medical Loss Ratio Improvement Act (Stark) MLRs for Medigap policies
H.R. 2958, Federal Employee Short-Term Disability Insurance Act (Holmes Norton) disability program for federal employees
H.R. 5838, Health Insurance Industry Antitrust Enforcement Act (Conyers) changes to McCarran-Ferguson Act
H.R.6283, Guaranteed Access to Health Insurance Act (Burgess) reinsurance, high risk pools
S. 137, Health Insurance Rate Review Act (Feinstein) rate review
S. 159, Confidence in Long-Term Care Insurance Act (Kohl) LTC insurance reforms
S. 1416, Medigap Medical Loss Ratio Improvement Act (Kerry) MLRs for Medigap policies
S. 1500, Ensure Children Have Health Care Act (Murkowski/Enzi) enrollment period for child-only policies
S. 2068, Access to Independent Health Insurance Advisors Act (Landrieu/Isakson) agent commissions, medical loss ratios
S. 2288, Access to Independent Health Insurance Advisors Act (Landrieu/Isakson) agent commissions, medical loss ratios
S. 3229, Long-Term Care Insurance Consumer Right-to-Know Act (Klobuchar) -- model disclosure form for marketing long-term care insurance policies
S. 3230, Long-Term Care Integrity Act (Klobuchar) -- claims dispute resolution procedures
S. 3271, Equal Access to Medicare Options Act (Kerry) Medigap provisions, MA enrollment provisions
Regulatory Issues:
Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; summary of benefits and coverage disclosures; medical loss ratios; review of rates for reasonableness; health insurance exchanges; pre-existing condition insurance plans; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health insurance web portal requirements; dependent coverage; treatment of expatriate plans; compliance with the transitional reinsurance program; and other issues relating to health care reform implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of, White House Office, Justice - Dept of (DOJ), Federal Bureau of Investigation (FBI), Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeremy |
Allen |
|
|
|
Carmella |
Bocchino |
|
|
|
Kathleen |
Callanan |
|
|
|
Dan |
Durham |
|
|
|
Paul |
Eiting |
|
|
|
Colleen |
Gallaher |
|
|
|
Gregory |
Gierer |
|
|
|
Donna |
Horoschak |
|
|
|
Karen |
Ignagni |
|
|
|
Erik |
Komendant |
|
|
|
Amber |
Manko |
|
|
|
Thomas |
Meyers |
|
|
|
Julie |
Miller |
|
|
|
Dana |
Mott-Bronson |
|
|
|
Betsy |
Pelovitz |
|
|
|
Candace |
Schaller |
|
|
|
Jeanette |
Thornton |
|
|
|
Kelly |
Vogel |
|
|
|
Thomas |
Wilder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R.369, Health Savings and Affordability Act (Austria) HSA improvements
16. Specific Lobbying Issues (continued):
H.R. 436, Health Care Cost Reduction Act (Paulsen) HSA, HRA, FSA provisions, ACA provisions
H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act (Reichert) repeal of HSA and FSA restrictions
H.R. 524, Restoring Consumer-driven Health Care Act (Quayle) repeal of HSA restrictions
H.R. 605, Patients' Freedom to Choose Act (Paulsen) repeal of HSA and FSA restrictions
H.R. 1004, Health Flexible Spending Arrangements Improvements Act (Boustany) -- distribution of unused amounts from a Health FSA
H.R. 1370, Repeal of ACA Premium Tax (Boustany)
H.R. 2010, Family and Retirement Health Investment Act (Paulsen) HSA and FSA improvements
H.R. 2529, Restoring Access to Medication Act (Jenkins) use of HSA funds and FSA funds to purchase OTC medications
H.R. 5842, Restoring Access to Medication Act (Jenkins) use of HSA, HRA, and FSA funds for over-the-counter medications
H.R. 5858, Health Savings Accounts Improvements Act (Herger) HSA provisions
H.R. 6005, Long-Term Care and Retirement Security Act (Courtney) tax incentives for purchase of LTC insurance, consumer protections
H.R. 6088, Repeal of the Unfair Taxes on Health Care Act (Schweikert) repeal of ACA premium tax and restrictions on HSAs / FSAs
H.R. 6137, Helping Save Americans' Health Care Choices Act (Fleming) HSA and FSA provisions
H.R. 6162, Ensuring Women's Access to Free-Market Healthcare Act (Cassidy) pregnancy-related coverage by HSA plans
S. 312, Patients' Freedom to Choose Act (Hutchison) repeal of HSA and FSA restrictions
S. 1098, Family and Retirement Health Investment Act (Hatch) HSA and FSA improvements
S. 1368, Restoring Access to Medication Act (Roberts) use of HSA funds and FSA funds to purchase OTC medications
S. 1880, Jobs and Premium Protection Act (Barrasso) repeal of health insurance premium tax
S. 2237, Small Business Jobs and Tax Relief Act (Reid) amendment to repeal ACA premium tax
S. 2516, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues
S. 3187, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues
Regulatory Issues:
Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate, W-2 reporting requirements, and other issues relating to health care reform implementation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeremy |
Allen |
|
|
|
Carmella |
Bocchino |
|
|
|
Kathleen |
Callanan |
|
|
|
Dan |
Durham |
|
|
|
Colleen |
Gallaher |
|
|
|
Gregory |
Gierer |
|
|
|
Karen |
Ignagni |
|
|
|
Erik |
Komendant |
|
|
|
Kelly |
Vogel |
|
|
|
Thomas |
Wilder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: http://www.ahip.org/content/default.aspx?bc=31|42|54
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |